Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page
- ChecktodayChange DetectedThe page now displays a standard error screen indicating the content is temporarily unavailable. The previously visible study record details are no longer shown.SummaryDifference17%

- Check8 days agoChange DetectedThe study page now indicates the trial is no longer recruiting participants. The update notes that the last known status was set by Academic and Community Cancer Research United on 2024-07 and that the last verification status is Unknown.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page template; the study details shown remain the same.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe revision label on the page was updated from v3.6.2 to v3.6.3, indicating a minor page update without altering the study content.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer version of the study details page has been published.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study page now clearly indicates recruitment is closed with a 'No longer looking for participants' note. The page also adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading for consistency, reflecting navigation and terminology improvements.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.